Clinical trial
Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of…
NCT00399425 · Spanish National Health System, Other · Terminated
Key facts
| NCT number | NCT00399425 |
|---|---|
| Title | Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients |
| Official title | Triple-Blind Clinical Trial With Placebo Control to Evaluate the Efficacy of a Heparin of Low Molecular Weight (Bemiparin) for Treating Slow-Responding Ulcers in Diabetic Foot in Primary Care |
| Lead sponsor | Spanish National Health System, Other |
| Collaborators | Carlos III Health Institute Rovi Pharmaceuticals Laboratories Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Foot Ulcer, Diabetic, Diabetic Angiopathies |
| Intervention type | Drug |
| Interventions | bemiparin (low molecular weight heparin) |
| Enrollment | 84 |
| Start date | Jun 1, 2001 |
| Completion | Apr 1, 2004 |
| First posted | Nov 14, 2006 |
| Last update posted | Nov 14, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: